Disorders of Neuromuscular Transmission Caused by Drugs

New England Journal of Medicine

Volumn 301, Issue 8, 1979, Pages 409-413

  Koch Weser, Jan ^a   Argov, Zohar ^a   Mastaglia, Frank L ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARDIOVASCULAR AGENT; CHLOROQUINE; HORMONE; PENICILLAMINE; PSYCHOTROPIC AGENT; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPYRETIC AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; PHENYTOIN;

AGED; ANIMAL; DRUG EFFECT; DRUG THERAPY; HUMAN; IATROGENIC DISEASE; MYASTHENIA GRAVIS; NERVE ENDING; NEUROMUSCULAR SYNAPSE; POSTOPERATIVE COMPLICATION; RESPIRATORY FAILURE; REVIEW; SYNAPTIC TRANSMISSION; SYNDROME; ADVERSE DRUG REACTION; DRUG INDUCED DISEASE; MUSCLE; MYASTHENIA; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; RESPIRATION DEPRESSION; RESPIRATORY SYSTEM; SHORT SURVEY; THERAPY;

AGED; ANIMAL; ANTIBIOTICS; ANTICONVULSANTS; CARDIOVASCULAR AGENTS; CHLOROQUINE; DRUG THERAPY; HORMONES; HUMAN; MOTOR ENDPLATE; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; PENICILLAMINE; POSTOPERATIVE COMPLICATIONS; PSYCHOTROPIC DRUGS; RESPIRATORY INSUFFICIENCY; SYNAPTIC TRANSMISSION; SYNDROME;

EID: 0018799297     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197908233010805     Document Type: Review

References (55)

1. Argov Z, Mastaglia FL: Drug-induced disorders of neuromuscular transmission. Adverse Drug React Bull 74: 264–267, 1979
2. Pittinger CB, Eryasa Y, Adamson R: Antibiotic-induced paralysis. Anesth Analg (Cleve) 49: 487–501, 1970
3. Way WL, Katzung BG, Larson CP Jr: Recurarization with quinidine. JAMA 200: 163–164, 1967
4. Weisman SJ: Masked myasthenia gravis. JAMA 141: 917–918, 1949
5. Herishanu Y, Rosenberg P: β-blockers and myasthenia gravis. Ann Intern Med 83: 834–835, 1975
6. Neil JF, Himmelhoch JM, Licata SM: Emergence of myasthenia gravis during treatment with lithium carbonate. Arch Gen Psychiatry 33: 1090–1092, 1976
7. Werman R, Wislicki L: Propranolol, a curariform and cholinomimetic agent at the frog neuromuscular junction. Comp Gen Pharmacol 2: 69–81, 1971
8. Vartanian GA, Chinyanga HM: The mechanism of acute neuromuscular weakness induced by chloroquine. Can J Physiol Pharmacol 50: 1099–1103, 1972
9. Rubbo JT, Gergis SD, Sokoll MD: Comparative neuromuscular effects of lincomycin and clindamycin. Anesth Analg (Cleve) 56: 329–332, 1977
10. Wright JM, Collier B: The site of the neuromuscular block produced by polymyxin B and rolitetracycline. Can J Physiol Pharmacol 54: 926–936, 1976
11. Galzigna L, Manani G, Mammano S, et al: Experimental study on the neuromuscular blocking action of procaine amide. Agressologie 13: 107–116, 1972
12. Yaari Y, Pincus JH, Argov Z: Depression of synaptic transmission by diphenylhydantoin. Ann Neurol 1: 334–338, 1977
13. Argov Z, Yaari Y: The action of chlorpromazine at an isolated cholinergic synapse. Brain Res 164: 227–236, 1979
14. Elmqvist D, Josefsson JO: The nature of the neuromuscular block produced by neomycin. Acta Physiol Scand 54: 105–110, 1962
15. Albuquerque EX, Eldefrawi AT, Eldefrawi ME, et al: Amantadine: neuromuscular blockade by suppression of ionic conductance of the acetylcholine receptor. Science 199: 788–790, 1978
16. McQuillen MP, Cantor HE, O'Rourke JR: Myasthenic syndrome associated with antibiotics. Arch Neurol 18: 402–415, 1968
17. Warner WA, Sanders E: Neuromuscular blockade associated with gentamicin therapy. JAMA 215: 1153–1154, 1971
18. Waterman PM, Smith RB: Tobramycin-curare interaction. Anesth Analg (Cleve) 56: 587–588, 1977
19. Lindesmith LA, Baines RD Jr, Bigelow DB, et al: Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med 68: 318–327, 1968
20. Wullen F, Kast G, Bruck A: Uber Nebenwirkungen bei Tetracyclin-Verabreichung an myastheniker. Dtsch Med Wochenschr 92: 667–669, 1967
21. Gibbels E: Weitere Beobachtungen zur Nebenwirkung intravenöser Reverin-Gaben bei Myasthenia gravis pseudoparalytica. Dtsch Med Wochenschr 92: 1153–1154, 1967
22. Samuelson RJ, Giesecke AH Jr, Kallus FT, et al: Lincomycin-curare interaction. Anesth Analg (Cleve) 54: 103–105, 1975
23. Fogdall RP, Miller RD: Prolongation of pancuronium-induced neuromuscular block by clindamycin. Anesthesiology 41: 407–408, 1974
24. Herishanu Y, Taustein I: The electromyographic changes induced by antibiotics: a preliminary study. Confin Neurol 33: 41–45, 1971
25. Bucknall RC: Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Proc R Soc Med 70: Suppl 3: 114–117, 1977
26. Seitz D, Hopf HC, Janzen RWC, et al: Penicillamin-induzierte myasthenie bei chronischer polyarthritis. Dtsch Med Wochenschr 101: 1153–1158, 1976
27. Delrieu F, Menkes C-J, Sainte-Croix A, et al: Myasthenie et thyroïdite auto-immune au cours du traitement de la polyarthrite rhumatoïde par la D-pénicillamine: étude anatomo-clinîque d'un cas. Ann Med Intern (Paris) 127: 739–743, 1976
28. Masters CL, Dawkins RL, Zilko PJ, et al: Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med 63: 689–694, 1977
29. Vincent A, Newsom-Davis J, Martin V: Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis. Lancet 1: 1254, 1978
30. Russell AS, Lindstrom JM: Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor. Neurology (Minneap) 28: 847–849, 1977
31. Jui-Yen T: Clinical and experimental studies on mechanism of neuromuscular blockade by chloroquine diorotate. Jpn J Anesth 20: 491–503, 1971
32. Kornfeld P, Horowitz SH, Genkins G, et al: Myasthenia gravis unmasked by antiarrhythmic agents. Mt Sinai J Med NY 43: 10–14, 1976
33. Grongono AW: Anaesthesia for atrial defibrillation: effect of quinidine on muscular relaxation. Lancet 2: 1039–1040, 1963
34. Drachman DA, Skom JH: Procainamide — a hazard in myasthenia gravis. Arch Neurol 13: 316–320, 1965
35. Hughes RO, Zacharias FJ: Myasthenic syndrome during treatment with practolol. Br Med J 1: 460–461, 1976
36. Dale RC, Schroeder ET: Respiratory paralysis during treatment of hypertension with trimethaphan camsylate. Arch Intern Med 136: 816–818, 1976
37. Poulton TJ, James FM III, Lockridge O: Prolonged apnea following trimethaphan and succinylcholine. Anesthesiology 50: 54–56, 1979
38. Usubiaga JE, Wikinski JA, Morales RL, et al: Interaction of intravenously administered procaine, lidocaine and succinylcholine in anesthetized subjects. Anesth Analg (Cleve) 46: 39–45, 1967
39. Norris FH Jr, Colella J, McFarlin D: Effect of diphenylhydantoin on neuromuscular synapse. Neurology (Minneap) 14: 869–876, 1964
40. Brumlik J, Jacobs RS: Myasthenia gravis associated with diphenylhydantoin therapy for epilepsy. Can J Neurol Sci 1: 127–129, 1974
41. Peterson H deC: Association of trimethadione therapy and myasthenia gravis. N Engl J Med 274: 506–507, 1966
42. Booker HE, Chun RWM, Sanguino M: Myasthenia gravis syndrome associated with trimethadione. JAMA 212: 2262–2263, 1970
43. Borden H, Clarke MT, Katz H: The use of pancuronium bromide in patients receiving lithium carbonate. Can Anaesth Soc J 21: 79–82, 1974
44. Hill GE, Wong KC, Hodges MR: Potentiation of succinylcholine neuromuscular blockade by lithium carbonate. Anesthesiology 44: 439–442, 1976
45. McQuillen MP, Gross M, Johns RJ: Chlorpromazine-induced weakness in myasthenia gravis. Arch Neurol 8: 286–290, 1963
46. Regan AG, Aldrete JA: Prolonged apnea after administration of promazine hydrochloride following succinylcholine infusion. Anesth Analg (Cleve) 46: 315–318, 1967
47. Bodley PO, Halwax K, Potts L: Low serum pseudocholinesterase levels complicating treatment with phenelzine. Br Med J 3: 510–512, 1969
48. Drachman DB: Myasthenia gravis and the thyroid gland. N Engl J Med 266: 330–333, 1962
49. Bickerstaff ER: Neurological Complications of Oral Contraceptives. London, Oxford University Press, 1975
50. Elder BF, Beal H, DeWald W, et al: Exacerbation of subclinical myasthenia by occupational exposure to an anesthetic. Anesth Analg (Cleve) 50: 383–387, 1971
51. Hodges RJH, Bennett JR, Tunstall ME: Effects of oxytocin on the response to suxamethonium. Br Med J 1: 413–416, 1959
52. Chasapakis G, Dimas C: Possible interaction between muscle relaxants and the kallikrein-trypsin inactivator “Trasylol”: report of three cases. Br J Anaesth 38: 838–839, 1966
53. Gesztes T: Prolonged apnoea after suxamethonium injection associated with eye drops containing an anticholinesterase agent: a case report. Br J Anaesth 38: 408–409, 1966
54. Ionescu-Drincǎ M, Serbǎnescu G, Nicolau C, et al: Association of myasthenic and neuritic symptoms following administration of antitetanic serum. Rev Roum Neurol 10: 239–243, 1973
55. Singh YN, Marshall IG, Harvey AL: Reversal of antibiotic-induced muscle paralysis by 3,4-diaminopyridine. J Pharm Pharmacol 30: 249–250, 1978